Literature DB >> 15771595

Correlation of the HER-2 protein expression and other clinicopathological features of ductal infiltrative breast cancer.

Svjetlana Radović1, Mirsad Babić, Mirsad Dorić, Edina Balta, Erol Kapetanović, Senad Secić.   

Abstract

The aim of the study was to investigate the relationship between the expression of the HER-2 membrane protein and other clinical-pathological parameters such as: histological size of the tumor, degree of the tumor's differentiation, presence of vascular invasion and presence of metastases in regional lymph nodes, in cases of ductal infiltrative breast cancer. We have investigated 56 cases of ductal infiltrative breast cancer. In all patients a mastectomy with a dissection of axillary lymph nodes has been performed. All tissue samples, taken by biopsy, were embedded in the paraffin, stained by hematoxylin-eosin technique and screened, and evaluation was performed by using a semiquantitative method of the immunohistochemical expression of the HER-2 protein. A decrease of the protein HER-2 expression was noticed in cases of an increase of the tumor's diameter above 50 mm. Increased expression of the HER-2 protein was noticed in cases of moderate (grade II) and poor (grade III) differentiation of carcinoma, as well as in cases where there was no metastases in the regional lymph nodes. No relationship has been observed between the expression of HER-2 and occurrence of vascular invasion. In cases of ductal infiltrative breast cancer the expression of HER-2 protein is in correlation with the size and degree of tumor's differentiation, as well as with the presence of metastases in regional lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771595      PMCID: PMC7214062          DOI: 10.17305/bjbms.2005.3327

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  23 in total

1.  Independent prognostic factors in breast cancer patients.

Authors:  M Narita; K Nakao; N Ogino; M Nakahara; A Onishi; M Tsujimoto
Journal:  Am J Surg       Date:  1998-01       Impact factor: 2.565

2.  The neu oncogene encodes an epidermal growth factor receptor-related protein.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

Review 3.  HER2 as a prognostic factor in breast cancer.

Authors:  S Ménard; S Fortis; F Castiglioni; R Agresti; A Balsari
Journal:  Oncology       Date:  2001       Impact factor: 2.935

Review 4.  Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside.

Authors:  W Hanna; H J Kahn; M Trudeau
Journal:  Mod Pathol       Date:  1999-08       Impact factor: 7.842

5.  Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Authors:  M F Press; M C Pike; V R Chazin; G Hung; J A Udove; M Markowicz; J Danyluk; W Godolphin; M Sliwkowski; R Akita
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

6.  p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression.

Authors:  B Wiesener; C E Hauser-Kronberger; E Zipperer; O Dietze; C Menzel; G W Hacker
Journal:  Histopathology       Date:  1998-12       Impact factor: 5.087

Review 7.  The biology of erbB-2/neu/HER-2 and its role in cancer.

Authors:  N E Hynes; D F Stern
Journal:  Biochim Biophys Acta       Date:  1994-12-30

8.  Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

Authors:  P P Rosen; M L Lesser; C D Arroyo; M Cranor; P Borgen; L Norton
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

9.  Histological grading of breast carcinomas: a study of interobserver agreement.

Authors:  P Robbins; S Pinder; N de Klerk; H Dawkins; J Harvey; G Sterrett; I Ellis; C Elston
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

10.  Prognostic significance of c-erbB-2 expression in node negative breast cancer.

Authors:  S Bianchi; M Paglierani; G Zampi; G Cardona; L Cataliotti; R Bonardi; S Ciatto
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  1 in total

1.  Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients.

Authors:  Li Ding; Zijin Zhang; Yan Xu; Yongqiang Zhang
Journal:  Bioengineered       Date:  2017-01-11       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.